- Published at
- by globenewswire.com
positive
positive
Cholangiocarcinoma Pipeline Insight: Therapeutic analysis of 70+ pipeline therapies and 70+ pharmaceutical companies
Cholangiocarcinoma Pipeline is majorly witnessing TAS-120, AG-120, E7090, and E7090 as the most anticipating therapies.